PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 26, 2026Critical Care Medicine0 citations

21: Evaluating Predictive Performance of Pediatric Logistic Organ Dysfunction-2 Score in Trauma Patients

View Full Paper
AKAnne KalinowskiCLChristine LeeperEFEricka L. Fink

Key Points

  • This research aims to evaluate the predictive performance of the PELOD-2 score for mortality in pediatric trauma patients across multiple ICU admission days.
  • Included pediatric trauma patients from a single tertiary care center from January 2021 to March 2024.
  • Extracted demographics, injury characteristics, and PELOD-2 scores from electronic medical records.
  • Assessed PELOD-2 performance at days 1, 3, and 5 post-admission using AUROC and AUPRC.
  • Utilized the Hosmer–Lemeshow test for calibration assessment.
  • Hospital mortality was 5.7%, with significantly higher PELOD-2 scores in non-survivors compared to survivors.
  • AUROC for day 1 was 0.88, day 3 was 0.91, and day 5 was 0.96, indicating strong discrimination.
  • AUPRC values were 0.65 for day 1, 0.88 for day 3, and 0.79 for day 5, supporting the predictive ability of the PELOD-2 score.
  • Calibration was adequate at all time points with p-values of 0.24, 0.83, and 0.93.

Abstract

Introduction: Multiorgan dysfunction scoring systems, including the Pediatric Logistic Organ Dysfunction-2 (PELOD-2), are used to predict mortality in pediatric intensive care unit (PICU) populations. We have previously shown that the day 1 PELOD-2 score has good discrimination p< 0.001. The PELOD-2 scores had strong discrimination at day 1, day 3, and day 5 with AUROC values of 0.88 (95% confidence interval, (0.69 –1.0), 0.91(0.84 –0.89), and 0.96 (0.94 –0.99) and corresponding AUPRCs of 0.65 (0.47 -0.84), 0.88 (0.76 –0.96), and 0.79 (0.59 –0.94). Calibration of the PELOD-2 scores at day 1, day 3, and day 5 were also adequate at p=0.24, p=0.83, and p=0.93. Conclusions: The PELOD-2 score demonstrated strong discrimination and acceptable calibration at day 1, day 3, and day 5 post-trauma, indicating robust predictive performance for mortality in pediatric trauma patients. Validation of these results are required in larger multi-center populations. These findings support the use of PELOD-2 as an outcomes measure in future trauma-focused clinical trials.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kalinowski et al. (2026) studied this question.

synapsesocial.com/papers/69c4ccd6fdc3bde4489187a3https://doi.org/10.1097/01.ccm.0001182276.64929.60
Ask AI
Helpful
Bookmark
Share
View Full Paper